• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的骨骼后果。

Skeletal consequences of heart failure.

机构信息

Division of Endocrinology and Diabetes, Agamenon Magalhães Hospital, Faculty of Medical Sciences, University of Pernambuco (UPE), Recife, Brazil.

出版信息

Womens Health (Lond). 2022 Jan-Dec;18:17455057221135501. doi: 10.1177/17455057221135501.

DOI:10.1177/17455057221135501
PMID:36321835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9634191/
Abstract

Heart failure (HF) is a prevalent clinical syndrome that causes significant physical limitations. Osteoporosis is also an important cause of loss of functionality, and it mainly affects women. There are several reports linking HF and osteoporosis, and both share risk factors. Most of the data available so far point to bone fragility as a consequence of HF, and several mechanisms have been identified to explain this relationship. Among the proposed pathophysiological mechanisms are the hyperactivation of the renin-angiotensin-aldosterone system and the increase in parathyroid hormone, functional limitation, production of inflammatory mediators and the use of drugs for HF. The role of osteoprotegerin has gained attention owing to its cardiovascular and skeletal effects, its observed deficiency during the postmenopausal period along with its compensatory increases in HF and severe osteoporosis. The objective of this review was to perform a literature search for the main evidence on skeletal impairment in HF, with emphasis on women. As for epidemiological studies, we selected data from 3 meta-analyses and 20 individual observational studies, which together showed the interrelationship between the two clinical conditions in terms of both decreased bone density and increased fracture risk. In conclusion, HF and osteoporosis are interrelated conditions mediated by complex pathophysiological mechanisms which may be more relevant for postmenopausal women, considered to be a vulnerable population for both cardiovascular diseases and bone fragility.

摘要

心力衰竭(HF)是一种常见的临床综合征,会导致严重的身体受限。骨质疏松症也是导致功能丧失的重要原因,主要影响女性。有几项报告将 HF 和骨质疏松症联系起来,两者有共同的危险因素。到目前为止,大多数可用数据表明,骨脆弱是 HF 的后果,已经确定了几种机制来解释这种关系。在提出的病理生理机制中,肾素-血管紧张素-醛固酮系统的过度激活和甲状旁腺激素的增加、功能受限、炎症介质的产生以及 HF 和严重骨质疏松症患者使用药物等。由于其对心血管和骨骼的影响,以及在绝经后期间观察到的骨保护素缺乏及其在 HF 和严重骨质疏松症中的代偿性增加,因此其作用引起了关注。本综述的目的是对 HF 骨骼损伤的主要证据进行文献检索,重点关注女性。就流行病学研究而言,我们选择了来自 3 项荟萃分析和 20 项单独观察性研究的数据,这些研究共同表明了这两种临床情况在骨密度降低和骨折风险增加方面的相互关系。总之,HF 和骨质疏松症是由复杂的病理生理机制介导的相互关联的疾病,对于绝经后妇女可能更为相关,她们被认为是心血管疾病和骨脆弱的高危人群。

相似文献

1
Skeletal consequences of heart failure.心力衰竭的骨骼后果。
Womens Health (Lond). 2022 Jan-Dec;18:17455057221135501. doi: 10.1177/17455057221135501.
2
Epidemiology, etiology, and diagnosis of osteoporosis.骨质疏松症的流行病学、病因学及诊断
Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11. doi: 10.1016/j.ajog.2005.08.047.
3
Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.早发性卵巢功能不全/早绝经女性的骨骼健康:23 年的纵向分析。
Hum Reprod. 2024 May 2;39(5):1013-1022. doi: 10.1093/humrep/deae037.
4
Osteodensitometry in healthy postmenopausal women.健康绝经后女性的骨密度测定
Prescrire Int. 2008 Apr;17(94):68-72.
5
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.(亚)临床心血管疾病与骨量丢失和骨折风险增加相关;心血管疾病与骨质疏松症相关性的系统评价。
Arthritis Res Ther. 2011 Jan 17;13(1):R5. doi: 10.1186/ar3224.
6
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.原发性保健中 FRAX 的应用:绝经后妇女和老年男性的绝对骨折风险评估。
Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102.
7
Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study.健康绝经后女性所有骨质疏松相关骨折的独立预测因素:OFELY研究
Bone. 2003 Jan;32(1):78-85. doi: 10.1016/s8756-3282(02)00919-5.
8
Heart failure as a risk factor for osteoporosis and fractures.心力衰竭是骨质疏松症和骨折的危险因素。
Curr Osteoporos Rep. 2012 Dec;10(4):258-69. doi: 10.1007/s11914-012-0115-2.
9
The population burden of fractures originates in women with osteopenia, not osteoporosis.骨折的人群负担源于骨质减少的女性,而非骨质疏松症患者。
Osteoporos Int. 2006;17(9):1404-9. doi: 10.1007/s00198-006-0135-9. Epub 2006 May 13.
10
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.阿仑膦酸盐、依替膦酸盐、利塞膦酸盐、雷洛昔芬和特立帕肽用于预防和治疗绝经后骨质疏松症的系统评价与经济学评估
Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220.

引用本文的文献

1
Vitamin D Deficiency in Patients Hospitalized for Heart Failure Living in the Tropics.居住在热带地区因心力衰竭住院患者的维生素D缺乏症
Int J Heart Fail. 2023 Nov 14;6(2):84-90. doi: 10.36628/ijhf.2023.0025. eCollection 2024 Apr.
2
Bone quality, mineral density, and fractures in heart failure.心力衰竭中的骨质量、骨密度和骨折。
PLoS One. 2023 Nov 3;18(11):e0293903. doi: 10.1371/journal.pone.0293903. eCollection 2023.

本文引用的文献

1
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
2
Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study.老年慢性心力衰竭患者的骨密度与纽约心脏协会(NYHA)分级相关:一项回顾性研究。
Eur Geriatr Med. 2018 Apr;9(2):183-189. doi: 10.1007/s41999-018-0027-5. Epub 2018 Jan 18.
3
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.
绝经后女性骨质疏松症的管理:北美更年期协会2021年立场声明
Menopause. 2021 Sep 1;28(9):973-997. doi: 10.1097/GME.0000000000001831.
4
Influences of the IL-6 cytokine family on bone structure and function.白细胞介素 6 细胞因子家族对骨骼结构和功能的影响。
Cytokine. 2021 Oct;146:155655. doi: 10.1016/j.cyto.2021.155655. Epub 2021 Jul 28.
5
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases.骨保护素和 RANKL-RANK-OPG-TRAIL 信号轴在心力衰竭和其他心血管疾病中的作用。
Heart Fail Rev. 2022 Jul;27(4):1395-1411. doi: 10.1007/s10741-021-10153-2. Epub 2021 Jul 27.
6
Impact of heart failure severity on bone mineral density among older patients with heart failure.心力衰竭严重程度对老年心力衰竭患者骨密度的影响。
Heart Vessels. 2021 Dec;36(12):1856-1860. doi: 10.1007/s00380-021-01884-1. Epub 2021 Jun 3.
7
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.心力衰竭住院患者的肾功能和结局。
J Am Coll Cardiol. 2021 Jul 27;78(4):330-343. doi: 10.1016/j.jacc.2021.05.002. Epub 2021 May 11.
8
The Role of Interleukin-6 in Bone.白细胞介素-6在骨骼中的作用。
J Endocr Soc. 2020 Sep 7;4(10):bvaa112. doi: 10.1210/jendso/bvaa112. eCollection 2020 Oct 1.
9
Pathophysiology of heart failure.心力衰竭的病理生理学
Cardiovasc Diagn Ther. 2021 Feb;11(1):263-276. doi: 10.21037/cdt-20-302.
10
Osteosarcopenia: where osteoporosis and sarcopenia collide.骨质减少症:骨质疏松症和肌肉减少症的交集。
Rheumatology (Oxford). 2021 Feb 1;60(2):529-537. doi: 10.1093/rheumatology/keaa755.